STOCK MARKET BSE NSE

Covaxin late-stage efficacy trial result still weeks away, say sources

The new states where Bharat Biotech’s Covaxin was used, along with Covishield, on Monday included Chhattisgarh, Gujarat, Jharkhand, Kerala, Madhya Pradesh, Punjab and West Bengal.

Published: 26th January 2021 03:47 AM  |   Last Updated: 26th January 2021 08:37 AM   |  A+A-

covaxin

For representational purpose. (Photo | Ashwin Prasath, EPS)

By Express News Service

NEW DELHI: Covaxin, India’s first indigenously developed Covid-19 vaccine, administered to people in seven more states on Monday, but sources said the efficacy results of the doses from its late-stage trial could still be a few weeks away.

The new states where Bharat Biotech’s Covaxin was used, along with Covishield, on Monday included Chhattisgarh, Gujarat, Jharkhand, Kerala, Madhya Pradesh, Punjab and West Bengal.

Till Sunday, only 12 states were using both Covaxin and Serum Institute of India-manufactured Covishield.

Last week, Bharat Biotech had said that it had successfully administered second dose Covaxin to 13,000 or half of the total volunteers as part of its ongoing Phase-3 clinical trials of the jab.

The company had completed enrolment of the total 25,800 volunteers for the efficacy trial after it received permission for the sale or distribution of Covaxin for restricted use in emergency situations in the public interest as an abundant precaution, in clinical trial mode, from the DCGI.

The vaccine-maker in the fact sheet on Covaxin, posted in its website, had said the clinical efficacy of the vaccine is yet to be established and is being studied in Phase-3 clinical trial and hence, it is crucial for vaccine recipients even after taking the shots, to maintain all other precautions related to Covid-19 need not be followed.

The government, which has been aggressively campaigning for the prioritised beneficiaries to come forward for the jabs that both the vaccines approved in the country are “safe and efficacious”.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp